Clinical trial
Arginine Malaria Trial: Study of Adjunctive Arginine in Falciparum Malaria
NCT00147368 · Menzies School of Health Research, Other · Completed
Key facts
| NCT number | NCT00147368 |
|---|---|
| Title | Arginine Malaria Trial: Study of Adjunctive Arginine in Falciparum Malaria |
| Official title | Pharmacokinetic-Pharmacodynamic Study of Adjunctive Arginine in Falciparum Malaria |
| Lead sponsor | Menzies School of Health Research, Other |
| Collaborators | Wellcome Trust National Health and Medical Research Council, Australia MSHR National Institute of Health Research and Development, Ministry of Health Republic of Indonesia Rumah Sakit Mitra Masyarakat… |
| Status | Completed |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | Malaria, Falciparum |
| Intervention type | Drug |
| Interventions | intravenous (IV) arginine |
| Enrollment | 50 |
| Start date | Feb 1, 2005 |
| Primary completion | Apr 1, 2006 |
| Completion | Dec 1, 2007 |
| First posted | Sep 7, 2005 |
| Last update posted | Jun 2, 2008 |
| Countries | Indonesia |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: